Session Details

F038 Autoimmune Blistering Diseases: What's New?

Sat, Mar 28, 1:00 PM - 3:00 PM
Room 301
2 CME Available Forum Upcoming
View Map

DESCRIPTION

This session will focus on new advances in AIBD regarding the current treatments and treatments in trials for pemphigus, pemphigoids, LABD and EBA, along with how these may change the way these conditions are managed.

LEARNING OBJECTIVES

1.

Discuss the evidence behind current and new treatments for pemphigoid and how this will change clinical practice

2.

Discuss the evidence behind current treatments and treatments in trials for pemphigus and pitfalls in trial design

3.

Discuss the current and potential new treatments in trials for LABD, MMP and EBA

SCHEDULE

1:00 PM

Introduction to session and speakers

Dedee F. Murrell, MD, FAAD

1:05 PM

Evidence based treatment for pemphigus

Victoria P. Werth, MD, FAAD

1:25 PM

Biological treatments for Bullous pemphigoid

Dedee F. Murrell, MD, FAAD

1:45 PM

A debate - methotrexate is better for bullous pemphigoid maintenance

Pascal Joly, MD, PhD, IFAAD

2:00 PM

A debate : dupilumab is better for control of BP

Frederic Caux, PhD

2:15 PM

Q & A and voting over debate

2:35 PM

Management of Linear IgA bullous dermatosis

Aikaterini Patsatsi, MD, PhD, IFAAD

DIRECTOR

Dedee F. Murrell, MD, FAAD

Dedee F. Murrell, MD, FAAD

SPEAKERS

Frederic Caux, PhD

Frederic Caux, PhD

Pascal Joly, MD, PhD, IFAAD

Pascal Joly, MD, PhD, IFAAD

Aikaterini Patsatsi, MD, PhD, IFAAD

Aikaterini Patsatsi, MD, PhD, IFAAD

Victoria P. Werth, MD, FAAD

Victoria P. Werth, MD, FAAD

DISCLOSURES

Frederic Caux, PhD

arGEN-X – Investigator(Fees); Boehringer Ingelheim – Advisory Board(Honoraria); Eli Lilly – Speaker(Honoraria); Galderma – Advisory Board(Honoraria); LEO Laboratories Ltd (LEO Pharma) – Speaker(Honoraria); Regeneron – Investigator(Fees); Sanofi – Advisory Board(Honoraria), Speaker(Honoraria);

Pascal Joly, MD, PhD, IFAAD

AbbVie – Consultant (1099 relationship)(Fees); arGEN-X – Consultant(Honoraria); AstraZeneca – Consultant(Honoraria); BMS – Advisory Board(Honoraria); Glycoera – Consultant (1099 relationship)(Honoraria); janssen – Advisory Board(Honoraria); Lilly ICOS LLC – Consultant(Honoraria); Novartis Pharmaceuticals Corp. – Consultant(Honoraria); sanofi-aventis – Consultant(Honoraria); TOPAZ Pharmaceuticals, Inc. – Consultant(Honoraria); UCB – Advisory Board(Honoraria);

Dedee F. Murrell, MD, FAAD

Abbott Laboratories – Advisory Board(Honoraria), Speaker(Honoraria); AbbVie – Investigator(Grants/Research Funding); Actavis – Speaker/Faculty Education(Honoraria); Almirall – Consultant(Honoraria); Amgen – Investigator(Fees); Amicus Therapeutics – Advisory Board(Honoraria); Amryt Pharma – Investigator(Fees); Anacor Pharmaceuticals, Inc. – Investigator(Grants/Research Funding); Arena Pharmaceuticals – Investigator(Grants/Research Funding); arGEN-X – Investigator(Fees); Ascent Pharmaceuticals – Speaker(Honoraria); Castle Creek Pharmaceuticals – Consultant(Fees); Chiesi Farmaceutici – Advisory Board(Fees); CSL – Speaker(Grants/Research Funding), Speaker(Honoraria); Delfin Technology – Investigator(Equipment); Eli Lilly and Company – Advisory Board(Honoraria); Galderma Laboratories, L.P. – Investigator(Grants/Research Funding), Investigator(Other Financial Benefit); Janssen-Ortho Inc. – Other(Grants/Research Funding); Leo Pharma Inc – Speaker/Faculty Education(Honoraria); Medimmune – Investigator(Grants/Research Funding); Merck Serono – Investigator(Fees), Investigator(Grants/Research Funding); Molynlycke – Speaker(Grants/Research Funding); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Pierre Fabre Dermo-Cosmétique US – Speaker(Honoraria); Principia Biopharma Inc – Consultant(Honoraria); Roche Laboratories – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Samumed, LLC – Investigator(Grants/Research Funding); Sanofi – Advisory Board(Fees), Investigator(Fees), Investigator(Grants/Research Funding); Schering-Plough Corporation – Investigator(Grants/Research Funding), Speaker(Other Financial Benefit); Shire – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Stiefel a GSK company – Speaker(Honoraria); XOMA (US) LLC – Investigator(Grants/Research Funding);

Aikaterini Patsatsi, MD, PhD, IFAAD

AbbVie – Speaker(Honoraria); Argenx – Advisory Board(Honoraria); Innovaderm Research Inc. – Advisory Board(Honoraria); Johnson and Johnson – Speaker(Honoraria); Leo Pharma Inc – Speaker(Honoraria); Novartis Hellas – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Pharmaserv Lilly – Speaker(Honoraria); Sanofi – Speaker(Honoraria); UCB – Speaker(Honoraria);

Victoria P. Werth, MD, FAAD

AbbVie – Consultant (1099 relationship)(Fees); Amgen – Investigator(Grants/Research Funding); AnaptysBio – Consultant(Honoraria); Architect Therapeutics – Consultant (1099 relationship)(Fees); argenx – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Astra Zeneca – Investigator(Grants/Research Funding); AstraZeneca – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Data Safety Monitoring Board(Honoraria); Atticus Pharma, Inc. – Consultant (1099 relationship)(Honoraria); Biogen – Consultant(Honoraria), Investigator(Grants/Research Funding); BMS – Consultant(Honoraria); Boehringer Ingelheim – Consultant (1099 relationship)(Honoraria); Cabaletta Bio – Consultant (1099 relationship)(Honoraria); Celexor Bio – Consultant (1099 relationship)(Fees); Corbus Pharmaceuticals – Investigator(Grants/Research Funding); CSL Behring – Consultant(Honoraria), Investigator(Grants/Research Funding); Cugene – Consultant(Honoraria); Duality Bio – Consultant (1099 relationship)(Fees); EMD Serono – Consultant(Honoraria); Everest Clinical Research – Consultant (1099 relationship)(Honoraria); Exo Therapeutics – Consultant (1099 relationship)(Honoraria); Gilead Sciences – Consultant(Honoraria), Investigator(Grants/Research Funding); GlaxoSmithKline – Consultant(Honoraria); Glycoera – Investigator(Grants/Research Funding); Horizon Pharma, Inc. – Investigator(Grants/Research Funding); Immunovant – Consultant (1099 relationship)(Honoraria); Janssen Pharmaceuticals, Inc – Consultant(Honoraria), Investigator(Grants/Research Funding); Kyowa Hakko Kirin Pharma, Inc. – Consultant(Honoraria); Lilly ICOS LLC – Consultant(Honoraria); Lumanity – Consultant (1099 relationship)(Honoraria); Lupus Foundation of America – Consultant(Honoraria); Merck & Co., Inc – Consultant(Honoraria); Novartis – Advisory Board(Honoraria); Nuvig Therapeutics – Consultant (1099 relationship)(Honoraria); Odyssey Therapeutics – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Priovant Therapeutics – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); ROME Therapeutics – Consultant(Honoraria); Sanofi Aventis – Consultant(Honoraria); UCB – Consultant(Honoraria); Ventus Therapeutics – Investigator(Grants/Research Funding); Viela Bio – Consultant(Honoraria), Investigator(Grants/Research Funding); Vindico Medical Education – Speaker/Faculty Education(Honoraria);